Related Experiment Video
Updated: Mar 8, 2026

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
Sex Differences in Metabolic Cardiomyopathy
Insights
Diabetic cardiomyopathies disproportionately affect women. This review explores sex-based differences in metabolism, calcium handling, and nitric oxide signaling pathways contributing to this disparity in heart disease.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Disorders
Background:
- Diabetic cardiomyopathies are more prevalent in women than men, unlike ischemic cardiomyopathies.
- Diabetes increases cardiovascular disease risk, with a notable sexual dimorphism: heart disease is 5x more common in diabetic women vs. 2x in diabetic men.
- Heart failure with preserved ejection fraction, linked to metabolic syndrome, is also more common in women.
Purpose of the Study:
- To review potential mechanisms underlying sex differences in metabolic cardiomyopathies.
- To evaluate sex differences in metabolism, calcium handling, nitric oxide, and structural proteins.
- To focus on signaling pathways, specifically nitric oxide synthase and PPARα, in regulating these sex differences.
Main Methods:
- Literature review of studies investigating sex differences in metabolic cardiomyopathies.
- Evaluation of sex-specific alterations in cardiac metabolism.
- Assessment of sex-based differences in calcium handling and nitric oxide pathways.
Main Results:
- Women exhibit distinct metabolic profiles and calcium handling in the context of diabetes.
- Nitric oxide synthase and PPARα signaling pathways show sex-dependent regulation.
- These pathways are implicated in the development of cardiac hypertrophy and heart failure in a sex-specific manner.
Conclusions:
- Sex differences in metabolism, calcium handling, and nitric oxide signaling contribute to the higher prevalence of diabetic cardiomyopathies in women.
- Targeting sex-specific pathways like nitric oxide synthase and PPARα may offer novel therapeutic strategies for diabetic heart disease.
- Understanding these sex differences is crucial for developing effective, personalized treatments for metabolic cardiomyopathies.
Abstract:
In contrast to ischemic cardiomyopathies which are more common in men, women are over-represented in diabetic cardiomyopathies. Diabetes is a risk factor for cardiovascular disease; however, there is a sexual dimorphism in this risk factor: heart disease is five times more common in diabetic women but only two-times more common in diabetic men. Heart failure with preserved ejection fraction, which is associated with metabolic syndrome, is also more prevalent in women. This review will examine potential mechanisms for the sex differences in metabolic cardiomyopathies. Sex differences in metabolism, calcium handling, nitric oxide, and structural proteins will be evaluated. Nitric oxide synthase and PPARα exhibit sex differences and have also been proposed to mediate the development of hypertrophy and heart failure. We focused on a role for these signalling pathways in regulating sex differences in metabolic cardiomyopathies.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...

